Cargando…
The emerging landscape of EFGR tyrosine kinase inhibitors in lung adenocarcinoma—successes and challenges
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264087/ https://www.ncbi.nlm.nih.gov/pubmed/35813761 http://dx.doi.org/10.21037/jtd-22-432 |
| _version_ | 1784742897019518976 |
|---|---|
| author | Oduah, Eziafa I. Lee, Chung-Shien Seetharamu, Nagarashee |
| author_facet | Oduah, Eziafa I. Lee, Chung-Shien Seetharamu, Nagarashee |
| author_sort | Oduah, Eziafa I. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9264087 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92640872022-07-09 The emerging landscape of EFGR tyrosine kinase inhibitors in lung adenocarcinoma—successes and challenges Oduah, Eziafa I. Lee, Chung-Shien Seetharamu, Nagarashee J Thorac Dis Editorial AME Publishing Company 2022-06 /pmc/articles/PMC9264087/ /pubmed/35813761 http://dx.doi.org/10.21037/jtd-22-432 Text en 2022 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Oduah, Eziafa I. Lee, Chung-Shien Seetharamu, Nagarashee The emerging landscape of EFGR tyrosine kinase inhibitors in lung adenocarcinoma—successes and challenges |
| title | The emerging landscape of EFGR tyrosine kinase inhibitors in lung adenocarcinoma—successes and challenges |
| title_full | The emerging landscape of EFGR tyrosine kinase inhibitors in lung adenocarcinoma—successes and challenges |
| title_fullStr | The emerging landscape of EFGR tyrosine kinase inhibitors in lung adenocarcinoma—successes and challenges |
| title_full_unstemmed | The emerging landscape of EFGR tyrosine kinase inhibitors in lung adenocarcinoma—successes and challenges |
| title_short | The emerging landscape of EFGR tyrosine kinase inhibitors in lung adenocarcinoma—successes and challenges |
| title_sort | emerging landscape of efgr tyrosine kinase inhibitors in lung adenocarcinoma—successes and challenges |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264087/ https://www.ncbi.nlm.nih.gov/pubmed/35813761 http://dx.doi.org/10.21037/jtd-22-432 |
| work_keys_str_mv | AT oduaheziafai theemerginglandscapeofefgrtyrosinekinaseinhibitorsinlungadenocarcinomasuccessesandchallenges AT leechungshien theemerginglandscapeofefgrtyrosinekinaseinhibitorsinlungadenocarcinomasuccessesandchallenges AT seetharamunagarashee theemerginglandscapeofefgrtyrosinekinaseinhibitorsinlungadenocarcinomasuccessesandchallenges AT oduaheziafai emerginglandscapeofefgrtyrosinekinaseinhibitorsinlungadenocarcinomasuccessesandchallenges AT leechungshien emerginglandscapeofefgrtyrosinekinaseinhibitorsinlungadenocarcinomasuccessesandchallenges AT seetharamunagarashee emerginglandscapeofefgrtyrosinekinaseinhibitorsinlungadenocarcinomasuccessesandchallenges |